BECN1 and viral infectious disease: A cell‐permeable, autophagy‐inducing Tat‐Beclin‐1 peptide, TB‐peptide, were previously demonstrated therapeutic benefits in disease models related to reducing viral infection,46 improving cardiac performance during pressure overload,47 and enhancing the effectiveness of chemotherapy.32